세포배양 매트릭스 시장 규모, 점유율 및 동향 분석 보고서 : 제품 유형별, 형태별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Cell Culture Matrices Market Summary

The global cell culture matrices market size was estimated at USD 1.21 billion in 2025 and is anticipated to reach USD 2.23 billion by 2033, growing at a CAGR of 8.0% from 2026 to 2033. This growth is primarily driven by increasing demand for 3D cell culture models, rising adoption of cell-based assays in drug discovery and regenerative medicine, expanding applications in cancer research and tissue engineering, and the growing focus on biologics development and personalized medicine.

Global Cell Culture Matrices Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global cell culture matrices market based on product type, form, application, end use, and region.

• Product Type Outlook (Revenue, USD Million, 2021 - 2033)
• Natural Matrices
  • Basement Membrane Extracts (including Matrigel)
  • Fibrin-based Matrices
  • Hyaluronic Acid (HA)-based Matrices
  • Others
• Synthetic Matrices
  • PEG-based Hydrogels
  • Polyacrylamide Hydrogels
  • PVA-based Hydrogels
  • Others
• Hybrid Matrices
• Form Outlook (Revenue, USD Million, 2021 - 2033)
• Liquid/Solution Hydrogels
• Pre-formed Solid Scaffolds
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Drug Discovery & Toxicology Testing
• Disease & Pathophysiology Modeling
• Cell Biology & Mechanistic Research
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Academic & Government Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product Type
  • 1.2.2. Form
  • 1.2.3. Application
  • 1.2.4. End Use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Impact Analysis
    • 3.3.1.1. Rising Demand for 3D Cell Culture Models
    • 3.3.1.2. Increasing Adoption of Advanced Cell-Based Assay Systems Across Drug Development and Manufacturing
    • 3.3.1.3. Growing Expansion of Stem Cell Research and Regenerative Medicine
  • 3.3.2. Market Restraint Impact Analysis
    • 3.3.2.1. High Cost of Advanced Matrices and 3D Culture Systems
    • 3.3.2.2. Complex Regulatory Requirements for Advanced Biomaterials
  • 3.3.3. Market Challenges Analysis
  • 3.3.4. Market Opportunity Analysis
• 3.4. Case Study Insights
• 3.5. Business Environment Analysis
  • 3.5.1. PESTLE Analysis
  • 3.5.2. PORTER'S Five Forces Analysis

Chapter 4. Product Type Business Analysis

• 4.1. Product Type Segment Dashboard
• 4.2. Global Cell Culture Matrices Market Product Type, Movement Analysis
• 4.3. Global Cell Culture Matrices Market Size & Trend Analysis, by Product Type, 2021 to 2033 (USD Million)
• 4.4. Natural Matrices
  • 4.4.1. Global Natural Matrices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Basement Membrane Extracts (including Matrigel)
    • 4.4.2.1. Global Basement Membrane Extracts (Including Matrigel) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Fibrin-based Matrices
    • 4.4.3.1. Global Fibrin-based Matrices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. Hyaluronic Acid (HA)-based Matrices
    • 4.4.4.1. Global Hyaluronic Acid (HA)-based Matrices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.5. Others
    • 4.4.5.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Synthetic Matrices
  • 4.5.1. Global Synthetic Matrices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. PEG-based Hydrogels
    • 4.5.2.1. Global PEG-based Hydrogels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. Polyacrylamide Hydrogels
    • 4.5.3.1. Global Polyacrylamide Hydrogels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.4. PVA-based Hydrogels
    • 4.5.4.1. Global PVA-based Hydrogels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.5. Others
    • 4.5.5.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Hybrid Matrices
  • 4.6.1. Global Hybrid Matrices Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Form Business Analysis

• 5.1. Form Segment Dashboard
• 5.2. Global Cell Culture Matrices Market Form, Movement Analysis
• 5.3. Global Cell Culture Matrices Market Size & Trend Analysis, by Form, 2021 to 2033 (USD Million)
• 5.4. Liquid/Solution Hydrogels
  • 5.4.1. Global Liquid/Solution Hydrogels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Pre-formed Solid Scaffolds
  • 5.5.1. Global Pre-formed Solid Scaffolds Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Others
  • 5.6.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Application Business Analysis

• 6.1. Application Segment Dashboard
• 6.2. Global Cell Culture Matrices Market Application, Movement Analysis
• 6.3. Global Cell Culture Matrices Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Drug Discovery & Toxicology Testing
  • 6.4.1. Global Drug Discovery & Toxicology Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Disease & Pathophysiology Modeling
  • 6.5.1. Global Disease & Pathophysiology Modeling Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Cell Biology & Mechanistic Research
  • 6.6.1. Global Cell Biology & Mechanistic Research Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. End Use Business Analysis

• 7.1. End Use Segment Dashboard
• 7.2. Global Cell Culture Matrices Market End Use, Movement Analysis
• 7.3. Global Cell Culture Matrices Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Academic & Government Research Institutes
  • 7.4.1. Global Academic & Government Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Pharmaceutical & Biotechnology Companies
  • 7.5.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Contract Research Organizations (CROs)
  • 7.6.1. Global Contract Research Organizations (CROs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Cell Culture Matrices Market: Regional Estimates and Trend Analysis, by Product Type, Form, Application, & End Use

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 8.3. North America
  • 8.3.1. North America Cell Culture Matrices Market, 2021 - 2033 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. U.S. Cell Culture Matrices Market, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Canada Cell Culture Matrices Market, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Mexico Cell Culture Matrices Market, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Cell Culture Matrices Market, 2021 - 2033 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. UK Cell Culture Matrices Market, 2021 - 2033 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Germany Cell Culture Matrices Market, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. France Cell Culture Matrices Market, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Italy Cell Culture Matrices Market, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Spain Cell Culture Matrices Market, 2021 - 2033 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Denmark Cell Culture Matrices Market, 2021 - 2033 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Sweden Cell Culture Matrices Market, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Norway Cell Culture Matrices Market, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Cell Culture Matrices Market, 2021 - 2033 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Japan Cell Culture Matrices Market, 2021 - 2033 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. China Cell Culture Matrices Market, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. India Cell Culture Matrices Market, 2021 - 2033 (USD Million)
    • 8.5.4.5.
  • 8.5.5. Australia
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Australia Cell Culture Matrices Market, 2021 - 2033 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Thailand Cell Culture Matrices Market, 2021 - 2033 (USD Million)
  • 8.5.7. South Korea
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. South Korea Cell Culture Matrices Market, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Cell Culture Matrices Market, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Brazil Cell Culture Matrices Market, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Argentina Cell Culture Matrices Market, 2021 - 2033 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA Cell Culture Matrices Market, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. South Africa Cell Culture Matrices Market, 2021 - 2033 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Saudi Arabia Cell Culture Matrices Market, 2021 - 2033 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. UAE Cell Culture Matrices Market, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Kuwait Cell Culture Matrices Market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2025
• 9.4. Company Profiles/Listing
  • 9.4.1. Corning Incorporated
    • 9.4.1.1. Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. Thermo Fisher Scientific Inc.
    • 9.4.2.1. Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. Merck KGaA (MilliporeSigma)
    • 9.4.3.1. Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. Bio-Techne Corporation
    • 9.4.4.1. Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. 3D Biotek LLC
    • 9.4.5.1. Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. AMSBIO
    • 9.4.6.1. Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. Sartorius AG
    • 9.4.7.1. Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. ReproCELL
    • 9.4.8.1. Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Strategic Initiatives
  • 9.4.9. Advanced BioMatrix Inc.
    • 9.4.9.1. Overview
    • 9.4.9.2. Financial Performance
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Strategic Initiatives
  • 9.4.10. Cellendes GmbH
    • 9.4.10.1. Overview
    • 9.4.10.2. Financial Performance
    • 9.4.10.3. Product Benchmarking
    • 9.4.10.4. Strategic Initiatives